HIV patient advocates protested outside and inside Gilead Sciences Inc.’s annual shareholder meeting Thursday, pleading for the world’s largest AIDS drug developer to cut the prices it charges cash-strapped government safety net programs.
About 20 people protested outside the Westin San Francisco Airport hotel, saying that the Foster City-based company (NASDAQ: GILD) could take a haircut on the $10,000 price it charges state AIDS drug assistance programs, or ADAPs.
No comments:
Post a Comment